查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2141590

2026 年至 2035 年經腸營養原料的市場機會、成長促進因素、產業趨勢與預測。

Enteral Nutrition Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 209 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球經腸營養成分市場預計到 2025 年將達到 43.1 億美元，年複合成長率為 7.3%，到 2035 年將達到 85.8 億美元。

市場範圍
開始年份 2025
預測期 2026-2035
起始金額 43.1億美元
預測金額 85.8億美元
複合年成長率 7.3

慢性疾病負擔日益加重，以及對臨床營養解決方案的需求不斷成長，推動了市場擴張，而長期營養支持的需求也不斷成長。由於腸內營養具有成本效益高、併發症風險低、患者復健效果好等優點，醫療保健專業人員越來越傾向於選擇經腸營養而非其他營養補充方法。這一持續趨勢直接推動了對蛋白質、碳水化合物、脂類、維生素和礦物質等關鍵營養素的需求。人口結構變化也發揮重要作用，全球老年人口的成長需要專業的營養管理。醫療保健和護理機構中老年護理服務的擴展促使製造商開發易於消化且營養最佳化的成分。同時，成分加工和配方技術的不斷創新正在提高產品的功效、耐受性和臨床適用性，從而進一步促進市場成長。

預計到2025年，碳水化合物原料市場規模將達到13.6億美元，並在2026年至2035年間維持6.7%的複合年成長率。各類原料的成長均受到日益複雜的配方要求和不斷發展的臨床營養標準的推動。蛋白質配方產品不斷增加，以支持肌肉的維持和恢復；碳水化合物原料產品也在不斷改進，以提供持久能量並增強代謝反應。脂質和脂肪產品擴大被製成特殊結構，以提高吸收率和消化率。原料功能性的擴展正在拓寬其應用範圍，從標準營養製劑到針對特定疾病的製劑。

預計到2025年，急診和加護病房（ICU）應用領域的市場規模將達到15.6億美元，市佔率為36.3%，到2035年複合年成長率（CAGR）為6.6%。臨床營養實踐的改變導致急性護理環境中經腸營養的早期啟動，從而增加了對支持代謝穩定和器官功能的成分的需求。此外，營養支持擴大融入疾病管理流程，導致配方複雜性增加，成分的使用範圍也擴大。

預計到2025年，北美經腸營養原料市場規模將達到17.9億美元，並在整個預測期內保持強勁成長。該地區受益於先進的醫療基礎設施、完善的報銷系統以及醫院和居家照護機構中臨床營養的廣泛應用。美國由於人口老化和長期健康問題高發，在該市場中扮演核心角色，臨床指南也日益強調使用特定蛋白質、脂質、纖維和微量營養素進行有針對性的營養干預。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 成長促進因素
    • 產業潛在風險與挑戰
    • 市場機遇
  • 成長潛力分析
  • 監理情勢
  • 波特的分析
  • PESTLE分析
  • 價格趨勢
    • 按地區
    • 依產品
  • 未來市場趨勢
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 專利趨勢
  • 貿易統計資料（註：貿易統計僅涵蓋主要國家）
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續計劃
    • 減少廢棄物策略
    • 生產中的能源效率
    • 具有環保意識的舉措
  • 考慮碳足跡

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估算與預測：依原料類型分類，2022-2035年

  • 蛋白質原料
    • 總蛋白
    • 水解蛋白質/胜肽
    • 遊離胺基酸
    • 功能性胺基酸
  • 碳水化合物原料
    • 麥芽糊精
    • 玉米糖漿固態/葡萄糖
    • 複合碳水化合物
    • 單醣
  • 脂肪/脂質成分
    • 長鏈三酸甘油酯（LCTs）
    • 中鏈三酸甘油酯（MCT）
    • ω-3脂肪酸
    • 單元不飽和脂肪酸（MUFA）
    • 結構化脂質和混合乳化劑
  • 纖維原料
    • 水溶性膳食纖維
    • 不溶性膳食纖維
    • 抗解澱粉
    • 益生元纖維
  • 微量營養素來源
    • 維他命
    • 礦物
    • 電解質
    • 微量元素
  • 功能性和增強免疫力的營養成分
    • 核苷酸
    • 益生菌
    • 抗氧化劑
    • 生物活性胜肽
  • 其他

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 重症監護/加護病房（ICU）
  • 腫瘤學/癌症
  • 消化系統疾病
  • 神經病變
  • 代謝性疾病
  • 其他

第7章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他中東和非洲國家

第8章：公司簡介

  • Abbott
  • Nutricia（Danone）
  • Nestle Health Science
  • Fresenius Kabi
  • Otsuka Pharmaceutical
  • RAUMEDIC AG
  • EA Pharma
  • Meiji
  • Arla Foods Ingredients
簡介目錄
Product Code: 15570

The Global Enteral Nutrition Ingredients Market was valued at USD 4.31 billion in 2025 and is estimated to grow at a CAGR of 7.3% to reach USD 8.58 billion by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$4.31 Billion
Forecast Value$8.58 Billion
CAGR7.3%

Market expansion is supported by the rising demand for long-term nutritional support driven by the growing burden of chronic health conditions and the expanding need for clinical nutrition solutions. Healthcare providers are increasingly favoring enteral nutrition over alternative feeding approaches due to its cost efficiency, lower complication risks, and improved patient recovery outcomes. This sustained shift is directly driving demand for core nutritional ingredients, including proteins, carbohydrates, lipids, vitamins, and minerals. Demographic changes also play a critical role, as the global elderly population continues to grow and requires specialized nutritional management. Expanding geriatric care services across medical and assisted-care facilities is encouraging manufacturers to develop ingredients that are easier to digest and nutritionally optimized. In parallel, continuous innovation in ingredient processing and formulation technologies is enhancing product effectiveness, tolerance, and clinical applicability, further supporting market growth.

The carbohydrate ingredient segment accounted for USD 1.36 billion in 2025 and is projected to register a CAGR of 6.7% from 2026 to 2035. Growth across ingredient types is being shaped by more advanced formulation requirements and evolving clinical nutrition standards. Proteins are increasingly incorporated to support muscle preservation and recovery, while carbohydrate ingredients are being refined to deliver sustained energy and improved metabolic response. Lipids and fats are increasingly formulated into specialized structures to improve absorption and digestive tolerance. This broadening of ingredient functionality is expanding their application across both standard and condition-focused nutritional formulations.

The critical care and intensive care unit application segment generated USD 1.56 billion in 2025 and held a 36.3% share, with a CAGR of 6.6% through 2035. Shifts in clinical nutrition practices are driving earlier initiation of enteral feeding in acute care environments, increasing demand for ingredients that support metabolic stability and organ function. Nutritional support is also becoming increasingly integrated into disease management pathways, raising formulation complexity and ingredient utilization.

North America Enteral Nutrition Ingredients Market accounted for USD 1.79 billion in 2025 and is expected to maintain strong growth throughout the forecast period. The region benefits from advanced healthcare infrastructure, consistent reimbursement frameworks, and widespread adoption of clinical nutrition in hospital and home-care settings. The United States plays a central role due to its aging population and high incidence of long-term health conditions, with clinical guidelines increasingly emphasizing targeted nutrition interventions using specialized proteins, lipids, fibers, and micronutrients.

Key participants in the Global Enteral Nutrition Ingredients Market include Fresenius Kabi, Abbott, Meiji, Nutricia (Danone), Nestle Health Science, and other established suppliers. Companies operating in the enteral nutrition ingredients market are strengthening their competitive position through continuous product innovation and targeted ingredient development. Many players are investing in research to enhance the bioavailability, digestibility, and clinical efficacy of core ingredients. Strategic collaborations with healthcare providers and expansion of production capabilities are helping companies meet rising demand across hospital and home-care settings. Firms are also focusing on disease-specific formulations to align with evolving clinical protocols.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Ingredient Type
    • 2.2.3 Application
  • 2.3 TAM Analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and Environmental Aspects
    • 3.12.1 Sustainable Practices
    • 3.12.2 Waste Reduction Strategies
    • 3.12.3 Energy Efficiency in Production
    • 3.12.4 Eco-friendly Initiatives
  • 3.13 Carbon Footprint Considerations

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2022- 2035 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Protein Ingredients
    • 5.2.1 Whole Proteins
    • 5.2.2 Hydrolyzed Proteins/Peptides
    • 5.2.3 Free Amino Acids
    • 5.2.4 Functional Amino Acids
  • 5.3 Carbohydrate Ingredients
    • 5.3.1 Maltodextrins
    • 5.3.2 Corn Syrup Solids / Glucose
    • 5.3.3 Complex Carbohydrates
    • 5.3.4 Simple Sugars
  • 5.4 Fat / Lipid Ingredients
    • 5.4.1 Long-Chain Triglycerides (LCTs)
    • 5.4.2 Medium-Chain Triglycerides (MCTs)
    • 5.4.3 Omega-3 Fatty Acids
    • 5.4.4 Monounsaturated Fatty Acids (MUFA)
    • 5.4.5 Structured Lipids & Blended Emulsions
  • 5.5 Fiber Ingredients
    • 5.5.1 Soluble Fibers
    • 5.5.2 Insoluble Fibers
    • 5.5.3 Resistant Starch
    • 5.5.4 Prebiotic Fibers
  • 5.6 Micronutrient Ingredients
    • 5.6.1 Vitamins
    • 5.6.2 Minerals
    • 5.6.3 Electrolytes
    • 5.6.4 Trace Elements
  • 5.7 Functional & Immunonutrition Ingredients
    • 5.7.1 Nucleotides
    • 5.7.2 Probiotics
    • 5.7.3 Antioxidants
    • 5.7.4 Bioactive Peptides
  • 5.8 Others

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Critical care / intensive care unit (ICU)
  • 6.3 Oncology / cancer
  • 6.4 Gastrointestinal diseases
  • 6.5 Neurological disorders
  • 6.6 Metabolic disorders
  • 6.7 Others

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 Abbott
  • 8.2 Nutricia (Danone)
  • 8.3 Nestle Health Science
  • 8.4 Fresenius Kabi
  • 8.5 Otsuka Pharmaceutical
  • 8.6 RAUMEDIC AG
  • 8.7 EA Pharma
  • 8.8 Meiji
  • 8.9 Arla Foods Ingredients